DGAP-News

Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled

DGAP-News: aap Implantate AG / Key word(s): Quarter Results/Preliminary Results Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled 26.04.2021 / 14:35 The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap" or the "Company") has started the financial year 2021 with good sales growth. Although the first quarter was still strongly impacted by the still rampant COVID 19 pandemic, aap increased sales by 9% year-on-year to EUR 2.7 million (Q1/2020: EUR 2.5 million) according to preliminary figures. Taking into account constant exchange rates, the growth rate was even 12%. It should be noted that the COVID 19 pandemic last year was not reflected in the business development until mid-March, so that the realized sales growth is to be assessed all the higher against the backdrop of the continuing comprehensive lockdown measures, which were recently even tightened in some cases. Not least, at the end of March aap received customer orders from tenders with a total value of around EUR 0.5 million, which have now been postponed to the second quarter due to their late receipt. If the orders had been received on time, sales in the first quarter would have been visibly above EUR 3 million.   Sales Q1/2021 in KEUR Q1/2021 Q1/2020 Change Sales Germany USA USA Distributors USA Global Partners International (without USA) Europe (without Germany) BRICS Countries RoW (Rest of World) 2,699 653 736 709 27 1,310 466 492 352 2,479 566 759 572 187 1,154 535 258 361 +9%